000			04490nam a22007697a 4500
008			190521s20202020 xxu||||| |||| 00| 0 eng d
022			_a1878-0938
024			_a10.1016/j.carrev.2019.03.016 [doi]
024			_aS1553-8389(19)30220-9 [pii]
040			_aOvid MEDLINE(R)
099			_a31054801
245			_aUse, Safety and Effectiveness of Subintimal Angioplasty and Re-Entry Devices for the Treatment of Femoropopliteal Chronic Total Occlusions: A Systematic Review of 87 Studies and 4,665 Patients.
251			_aCardiovascular Revascularization Medicine. 21(1):34-45, 2020 01.
252			_aCardiovasc Revasc Med. 21(1):34-45, 2020 01.
252			_zCardiovasc Revasc Med. 2019 Mar 23
253			_aCardiovascular revascularization medicine : including molecular interventions
260			_c2020
260			_fFY2020
265			_saheadofprint
265			_sppublish
266			_d2019-05-21
268			_aCardiovascular Revascularization Medicine. 2019 Mar 23
269			_fFY2019
501			_aAvailable in print through MWHC library: 2002 - present
520			_aBACKGROUND: Subintimal angioplasty (SIA) is often utilized to cross femoropopliteal (FP) artery chronic total occlusions (CTOs). Re-entry devices (RED) can further assist with true lumen re-entry.
520			_aCONCLUSION: SIA with or without RED is a valuable alternative to intraluminal crossing for endovascular treatment of FP CTOs. Procedural success was excellent for both techniques, while the cumulative complication rate was numerically lower in the RED group. Short- and long-term outcomes were acceptable for both techniques.
520			_aCopyright (c) 2019. Published by Elsevier Inc.
520			_aMETHODS: A systematic review according to the PRISMA guidelines was performed. Quantitative synthesis was applied when possible.
520			_aOBJECTIVE: To systematically review the literature for studies reporting on the use of SIA, with or without RED.
520			_aRESULTS: 87 studies and 4665 patients (5161 lesions) were included (63.9% male). 46.7% of patients had critical limb ischemia at the time of the intervention. Two RED types were used (Pioneer and Outback). Sixty-eight studies included lesions treated with SIA without RED, 17 studies included lesions treated with RED only, and two studies included a comparison between the two treatment methods. In total, 3898 (83.6%) patients were treated with SIA without RED and 754 (12.2%) with RED. Procedural success rate ranged from 64.5%-100% (92.5% for SIA without RED, 88.3% for RED cases). The complication rate ranged from 1.6% - 28% among different studies (cumulative rates: SIA: 9.1%, RED 9.3%). Perforations occurred in 1.6% of the total population (n=46). Primary patency at one year ranged from 22% to 94.1%. Newer studies had a higher patency rate, ranging from 70% to 94.1%.
546			_aEnglish
650			_a*Angioplasty/is [Instrumentation]
650			_a*Femoral Artery
650			_a*Peripheral Arterial Disease/th [Therapy]
650			_a*Popliteal Artery
650			_a*Vascular Access Devices
650			_aAged
650			_aAged, 80 and over
650			_aAngioplasty/ae [Adverse Effects]
650			_aChronic Disease
650			_aConstriction, Pathologic
650			_aEquipment Design
650			_aFemale
650			_aFemoral Artery/dg [Diagnostic Imaging]
650			_aFemoral Artery/in [Injuries]
650			_aFemoral Artery/pp [Physiopathology]
650			_aHumans
650			_aMale
650			_aMiddle Aged
650			_aPeripheral Arterial Disease/dg [Diagnostic Imaging]
650			_aPeripheral Arterial Disease/pp [Physiopathology]
650			_aPopliteal Artery/dg [Diagnostic Imaging]
650			_aPopliteal Artery/in [Injuries]
650			_aPopliteal Artery/pp [Physiopathology]
650			_aRisk Factors
650			_aTime Factors
650			_aTreatment Outcome
650			_aVascular Patency
650			_aVascular System Injuries/et [Etiology]
651			_aMedStar Washington Hospital Centerumar
656			_aMedicine/General Internal Medicine
657			_aJournal Article
700			_aJonnalagadda, Anil K
790			_aArmstrong EJ, Avner SJ, Bakoyiannis C, Chaitidis N, Giri JS, Jonnalagadda AK, Kakkar A, Katsaros I, Kokkinidis DG, Secemsky EA
856			_uhttps://dx.doi.org/10.1016/j.carrev.2019.03.016 _zhttps://dx.doi.org/10.1016/j.carrev.2019.03.016
942			_cART _dArticle
999			_c4207 _d4207